Interações de Candesartana

Candesartana (Atacand), bloqueador do receptor da angiotensina II (BRA), tem 184 interações documentadas nas bulas da FDA e nas fichas informativas que indexamos (graves: 28; moderadas: 138; leves: 18; casos em que uma bula relata não haver interação significativa: 0). Cada item abaixo cita a frase em que se baseia. Esta página de medicamento é um ponto de partida, não um veredito para a sua situação.

Aparência de Candesartana

Todas as 20 versões
Candesartana 4 mg em comprimido: branco, redondo, 7 mm, sulcado, com a gravação ACF de um lado e 004 do outro.
ACF / 004
4 mg · branco · redondo · 7 mm · sulcado
ANI
Candesartana 8 mg em comprimido: rosa, redondo, 7 mm, sulcado, com a gravação ACG de um lado e 008 do outro.
ACG / 008
8 mg · rosa · redondo · 7 mm · sulcado
ANI
Candesartana 16 mg em comprimido: rosa, redondo, 7 mm, sulcado, com a gravação ACH de um lado e 016 do outro.
ACH / 016
16 mg · rosa · redondo · 7 mm · sulcado
ANI
Candesartana 32 mg em comprimido: rosa, redondo, 10 mm, sulcado, com a gravação ACL de um lado e 032 do outro.
ACL / 032
32 mg · rosa · redondo · 10 mm · sulcado
ANI

Representações criadas a partir das listas de produtos das bulas da FDA: cor, formato, tamanho e gravação. 20 versões documentadas de 8 fabricantes.

Interações segundo a bula

Interações graves (28)

  • Alisquirenoanti-hipertensivoGrave

    Do not co-administer aliskiren with candesartan cilexetil in patients with diabetes [see Drug Interactions (7.4) ] . (bula de Candesartana, Contraindicações)

  • Anlodipino + benazeprilbloqueador dos canais de cálcio di-hidropiridínicoGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Benazeprilinibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Benazepril + hidroclorotiazidainibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Captoprilinibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • ClozapinaantipsicóticoGrave

    Use CLOZARIL cautiously in patients with cardiovascular or cerebrovascular disease or conditions predisposing to hypotension (e.g., dehydration, use of antihypertensive medications) [see Dosage and Administration ( 2.2 , 2.6 ), Warnings and Precautions ( 5.2 )]. (bula de Clozapina, Advertência em caixa preta)

  • Enalaprilinibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Enalapril + hidroclorotiazidainibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Enalaprilateinibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Eplerenonaantagonista da aldosteronaGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Eptifibatidaantiagregante plaquetárioGrave

    …of active abnormal bleeding within the previous 30 days Severe hypertension (systolic blood pressure >200 mm Hg or diastolic blood pressure >110 mm Hg) not adequately controlled on antihypertensive therapy Major surgery within the preceding 6 weeks History of stroke within 30 days or any history of hemorrhagic stroke Current or planned administration of another… (bula de Eptifibatida, Contraindicações)

  • Espironolactonaantagonista da aldosteronaGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Espironolactona + hidroclorotiazidaantagonista da aldosteronaGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • FludrocortisonacorticosteroideGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Fosinoprilinibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Fosinopril + hidroclorotiazidainibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Lisinoprilinibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Lisinopril + hidroclorotiazidainibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Metolazonadiurético tiazídicoGrave

    Other Antihypertensive Drugs When metolazone tablets, USP, are used with other antihypertensive drugs, particular care must be taken to avoid excessive reduction of blood pressure, especially during initial therapy. (bula de Metolazona, Advertências)

  • MinoxidilvasodilatadorGrave

    Minoxidil should be reserved for hypertensive patients who do not respond adequately to maximum therapeutic doses of a diuretic and two other antihypertensive agents. (bula de Minoxidil, Advertência em caixa preta)

  • Moexiprilinibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Perindoprilinibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • PotássioVitaminas e mineraisGrave

    Esses medicamentos reduzem a excreção de potássio; acrescentar suplementos de potássio ou substitutos do sal pode causar hipercalemia, que afeta o ritmo cardíaco. (NIH Office of Dietary Supplements, Potassium)

  • Quinaprilinibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Quinapril + hidroclorotiazidainibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Ramiprilinibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

  • Tadalafilainibidor da PDE5Grave

    …coadministration of an alpha-blocker and CIALIS for the treatment of BPH has not been adequately studied, and due to the potential vasodilatory effects of combined use resulting in blood pressure lowering, the combination of CIALIS and alpha-blockers is not recommended for the treatment of BPH. [see Dosage and Administration ( 2.7 ), Drug Interactions ( 7.1 ),… (bula de Tadalafila, Advertências e precauções)

  • Trandolaprilinibidor da ECAGrave

    Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (bula de Candesartana, Interações medicamentosas)

Interações moderadas (138)

  • Acetazolamidainibidor da anidrase carbônicaModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Ácido acetilsalicílico + dipiridamolantiagregante plaquetárioModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Ácido etacrínicodiurético de alçaModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Ácido mefenâmicoAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • AlfaepoetinaModerada

    Following initiation and titration of Epogen, approximately 25% of patients on dialysis required initiation of or increases in antihypertensive therapy; hypertensive encephalopathy and seizures have been reported in patients with CKD receiving Epogen. (bula de Alfaepoetina, Advertências e precauções)

  • AlfuzosinaalfabloqueadorModerada

    Postural hypotension/syncope: Care should be taken in patients with symptomatic hypotension or who have had a hypotensive response to other medications or are concomitantly treated with antihypertensive medication or nitrates ( 5.1 ) (bula de Alfuzosina, Advertências e precauções)

  • Amiloridadiurético poupador de potássioModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Anfepramona (dietilpropiona)estimulante do SNCModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • AripiprazolantipsicóticoModerada

    Antihypertensive Drugs Due to its alpha-adrenergic antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents. (bula de Aripiprazol, Interações medicamentosas)

  • Armodafinilaestimulante do SNCModerada

    There was also a slightly greater proportion of patients on NUVIGIL requiring new or increased use of antihypertensive medications (2.9%) compared to patients on placebo (1.8%). (bula de Armodafinila, Advertências e precauções)

  • Articaína + epinefrinaanestésico localModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • AsenapinaantipsicóticoModerada

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (elderly patients, patients with dehydration, hypovolemia, concomitant treatment with antihypertensive medications, patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure, or conduction abnormalities), and patients… (bula de Asenapina, Advertências e precauções)

  • AtenololbetabloqueadorModerada

    Because of its relative beta 1 selectivity, however, TENORMIN may be used with caution in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (bula de Atenolol, Advertências)

  • Atenolol + clortalidonabetabloqueadorModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Atomoxetinainibidor da recaptação de noradrenalinaModerada

    Antihypertensive Drugs Prevention or Management Increase the frequency of monitoring blood pressure and adjust atomoxetine oral solution dosage as clinically appropriate. (bula de Atomoxetina, Interações medicamentosas)

  • Avanafilainibidor da PDE5Moderada

    • Use of avanafil with alpha-blockers, other antihypertensives, or substantial amounts of alcohol (greater than 3 units) may lead to hypotension ( 2.3 , 5.6 , 5.7 ) (bula de Avanafila, Advertências e precauções)

  • Benzfetaminaestimulante do SNCModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • BisoprololbetabloqueadorModerada

    Because of its relative beta 1 -selectivity, however, BISOPROLOL FUMARATE may be used with caution in patients with bronchospastic disease who do not respond to, or who cannot tolerate other antihypertensive treatment. (bula de Bisoprolol, Advertências)

  • Bisoprolol + hidroclorotiazidabetabloqueadorModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • BortezomibeModerada

    Hypotension: Use caution when treating patients taking antihypertensives, with a history of syncope, or with dehydration. (bula de Bortezomibe, Advertências e precauções)

  • BrexpiprazolantipsicóticoModerada

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, concomitant treatment with antihypertensive medication), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (bula de Brexpiprazol, Advertências e precauções)

  • Brimonidinaagonista alfa-adrenérgicoModerada

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (bula de Brimonidina, Interações medicamentosas)

  • Brimonidina + timololagonista alfa-adrenérgicoModerada

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate/timolol maleate ophthalmic solution may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate/timolol maleate ophthalmic solution is advised. (bula de Brimonidina + timolol, Interações medicamentosas)

  • Bromocriptinaagonista da dopaminaModerada

    Use caution in patients taking antihypertensive medications. (bula de Bromocriptina, Advertências e precauções)

  • Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • Bumetanidadiurético de alçaModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Bupivacaína + epinefrinaanestésico localModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Candesartana + hidroclorotiazidabloqueador do receptor da angiotensina II (BRA)Moderada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • CarbidopaModerada

    Symptomatic postural hypotension has occurred when carbidopa, given with levodopa or carbidopa-levodopa combination products, was added to the treatment of a patient receiving antihypertensive drugs. (bula de Carbidopa, Interações medicamentosas)

  • Carbidopa + levodopamedicamento dopaminérgicoModerada

    Antihypertensive drugs: May cause symptomatic postural hypotension. (bula de Carbidopa + levodopa, Interações medicamentosas)

  • Carbidopa + levodopa + entacaponamedicamento dopaminérgicoModerada

    Antihypertensive Agents Symptomatic postural hypotension has occurred when carbidopa/levodopa was added to the treatment of patients receiving antihypertensive drugs. (bula de Carbidopa + levodopa + entacapona, Interações medicamentosas)

  • CariprazinaantipsicóticoModerada

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive medications), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (bula de Cariprazina, Advertências e precauções)

  • CarvedilolbetabloqueadorModerada

    COREG may be used with caution, however, in patients who do not respond to, or cannot tolerate, other antihypertensive agents. (bula de Carvedilol, Advertências e precauções)

  • CelecoxibeAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • CetoprofenoAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • CetorolacoAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Ciclobenzaprinarelaxante muscularModerada

    …concomitant use of TONMYA with: MAO inhibitors may be life-threatening [see Contraindications (4) ] , Alcohol, barbiturates, and other CNS depressants may increase the risk of adverse reactions associated with these drugs, Tramadol may increase the seizure risk, Guanethidine or other similar acting drugs may block the antihypertensive action of these drugs. (bula de Ciclobenzaprina, Interações medicamentosas)

  • CiclosporinaimunossupressorModerada

    Caution is also required when cyclosporine is coadministered with potassium sparing drugs (e.g., angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists), potassium-containing drugs as well as in patients on a potassium rich diet. (bula de Ciclosporina, Interações medicamentosas)

  • Citrato de potássiosuplemento de potássioModerada

    Agents Increasing Serum Potassium Co-administration of candesartan cilexetil with potassium sparing diuretics, potassium supplements, potassium-containing salt substitutes or other drugs that raise serum potassium levels may result in hyperkalemia. (bula de Candesartana, Interações medicamentosas)

  • Cloreto de potássiosuplemento de potássioModerada

    Agents Increasing Serum Potassium Co-administration of candesartan cilexetil with potassium sparing diuretics, potassium supplements, potassium-containing salt substitutes or other drugs that raise serum potassium levels may result in hyperkalemia. (bula de Candesartana, Interações medicamentosas)

  • Clorotiazidadiurético tiazídicoModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Clortalidonadiurético tiazídicoModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Dexmetilfenidatoestimulante do SNCModerada

    • Antihypertensive Drugs: Monitor blood pressure. (bula de Dexmetilfenidato, Interações medicamentosas)

  • DiclofenacoAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • DiflunisalAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • DobutaminasimpaticomiméticoModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • Drospirenona + etinilestradiolanticoncepcional oralModerada

    Medications that may increase serum potassium concentration include ACE inhibitors, angiotensin-II receptor antagonists, potassium-sparing diuretics, potassium supplementation, heparin, aldosterone antagonists, and NSAIDS. (bula de Drospirenona + etinilestradiol, Advertências e precauções)

  • DroxidopasimpaticomiméticoModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • DuloxetinaIRSNModerada

    The risk of BP decreases may be greater in patients taking concomitant medications that induce orthostatic hypotension (such as antihypertensives) or are potent CYP1A2 inhibitors [see Drug Interactions ( 7.1 )] and in patients taking duloxetine delayed-release capsules at doses above 60 mg daily. (bula de Duloxetina, Advertências e precauções)

  • EfedrinasimpaticomiméticoModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • Epinefrina (adrenalina)simpaticomiméticoModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • Epoprostenolanálogo de prostaglandinaModerada

    Additional reductions in blood pressure may occur when VELETRI is administered with diuretics, antihypertensive agents, or other vasodilators. (bula de Epoprostenol, Interações medicamentosas)

  • EsmololbetabloqueadorModerada

    Antihypertensive agents clonidine, guanfacine, or moxonidine: Beta blockers also increase the risk of clonidine-, guanfacine-, or moxonidine-withdrawal rebound hypertension. (bula de Esmolol, Interações medicamentosas)

  • EtodolacoAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Fampridina (dalfampridina)suplemento de potássioModerada

    Agents Increasing Serum Potassium Co-administration of candesartan cilexetil with potassium sparing diuretics, potassium supplements, potassium-containing salt substitutes or other drugs that raise serum potassium levels may result in hyperkalemia. (bula de Candesartana, Interações medicamentosas)

  • Fendimetrazinaestimulante do SNCModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • Fenelzinainibidor da MAOModerada

    …hydrochloride desipramine hydrochloride imipramine hydrochloride doxepin carbamazepine cyclobenzaprine HCl amoxapine maprotiline HCl trimipramine maleate protriptyline HCl mirtazapine Phenelzine sulfate should be used with caution in combination with antihypertensive drugs, including thiazide diuretics and β-blockers, since exaggerated hypotensive effects may result. (bula de Fenelzina, Advertências)

  • FenilefrinadescongestionanteModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • FenoprofenoAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Fenterminaestimulante do SNCModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • FlurbiprofenoAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Furosemidadiurético de alçaModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Hidroclorotiazidadiurético tiazídicoModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • IbuprofenoAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • IloperidonaantipsicóticoModerada

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive medications), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (bula de Iloperidona, Advertências e precauções)

  • Indapamidadiurético tiazídicoModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • IndometacinaAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Irbesartana + hidroclorotiazidabloqueador do receptor da angiotensina II (BRA)Moderada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Isoprenalina (isoproterenol)agonista beta-adrenérgicoModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • Lidocaína + epinefrinaanestésico localModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • Lítiomedicamento serotoninérgicoModerada

    Lithium: Increases in serum lithium concentrations and toxicity ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Losartana + hidroclorotiazidabloqueador do receptor da angiotensina II (BRA)Moderada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • LumateperonaantipsicóticoModerada

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive drugs), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and patients… (bula de Lumateperona, Advertências e precauções)

  • LurasidonaantipsicóticoModerada

    Patients at increased risk of these adverse reactions or at increased risk of developing complications from hypotension include those with dehydration, hypovolemia, treatment with antihypertensive medication, history of cardiovascular disease (e.g., heart failure, myocardial infarction, ischemia, or conduction abnormalities), history of cerebrovascular disease,… (bula de Lurasidona, Advertências e precauções)

  • Mecamilaminaanti-hipertensivoModerada

    The action of Mecamylamine HCl may be potentiated by anesthesia, other antihypertensive drugs and alcohol. (bula de Mecamilamina, Interações medicamentosas)

  • MeloxicamAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Metanfetaminaestimulante do SNCModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • Metilfenidatoestimulante do SNCModerada

    Antihypertensive Drugs: Monitor blood pressure. (bula de Metilfenidato, Interações medicamentosas)

  • Metoprolol + hidroclorotiazidabetabloqueadorModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Midodrinaagonista alfa-adrenérgicoModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • Mirabegronaagonista beta-adrenérgicoModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • MirtazapinaantidepressivoModerada

    REMERON/REMERONSolTab should be used with caution in patients with known cardiovascular or cerebrovascular disease that could be exacerbated by hypotension (history of myocardial infarction, angina, or ischemic stroke) and conditions that would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medication). (bula de Mirtazapina, Advertências e precauções)

  • Modafinilaestimulante do SNCModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • NabumetonaAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • NaproxenoAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • NateglinidameglitinidaModerada

    Agents Increasing Serum Potassium Co-administration of candesartan cilexetil with potassium sparing diuretics, potassium supplements, potassium-containing salt substitutes or other drugs that raise serum potassium levels may result in hyperkalemia. (bula de Candesartana, Interações medicamentosas)

  • Antihypertensive Therapy Niacin may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension. (bula de Niacina (ácido nicotínico), Interações medicamentosas)

  • Nimodipinobloqueador dos canais de cálcio di-hidropiridínicoModerada

    Blood Pressure Lowering Drugs Nimodipine may increase the blood pressure lowering effect of concomitantly administered anti-hypertensives such as diuretics, beta-blockers, ACE inhibitors, angiotensin receptor blockers, other calcium channel blockers, α-adrenergic blockers, PDE5 inhibitors, and α-methyldopa. (bula de Nimodipino, Interações medicamentosas)

  • NitroglicerinanitratoModerada

    Antihypertensives: Possible additive hypotensive effects. (bula de Nitroglicerina, Interações medicamentosas)

  • OlanzapinaantipsicóticoModerada

    …of myocardial infarction or ischemia, heart failure, or conduction abnormalities), cerebrovascular disease, and conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications) where the occurrence of syncope, or hypotension and/or bradycardia might put the patient at increased medical risk. (bula de Olanzapina, Advertências e precauções)

  • Olanzapina + fluoxetinaantipsicóticoModerada

    …and fluoxetine capsules should be used with particular caution in patients with known cardiovascular disease (history of myocardial infarction or ischemia, heart failure, or conduction abnormalities), cerebrovascular disease, or conditions that would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications). (bula de Olanzapina + fluoxetina, Advertências e precauções)

  • Olmesartana + anlodipino + hidroclorotiazidabloqueador do receptor da angiotensina II (BRA)Moderada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Olmesartana + hidroclorotiazidabloqueador do receptor da angiotensina II (BRA)Moderada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • OxaprozinaAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • OximetazolinadescongestionanteModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • PaliperidonaantipsicóticoModerada

    Use ERZOFRI with caution in patients with known cardiovascular disease (e.g., heart failure, history of myocardial infarction or ischemia, conduction abnormalities), cerebrovascular disease, or conditions that predispose the patient to hypotension (e.g., dehydration, hypovolemia, and treatment with antihypertensive medications). (bula de Paliperidona, Advertências e precauções)

  • NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • PazopanibeModerada

    Monitor blood pressure as clinically indicated and initiate and adjust antihypertensive therapy as appropriate. (bula de Pazopanibe, Advertências e precauções)

  • PentoxifilinametilxantinaModerada

    Small decreases in blood pressure have been observed in some patients treated with pentoxifylline extended-release tablets; periodic systemic blood pressure monitoring is recommended for patients receiving concomitant antihypertensive therapy. (bula de Pentoxifilina, Interações medicamentosas)

  • PiroxicamAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Poliestirenossulfonato de sódiosuplemento de potássioModerada

    Agents Increasing Serum Potassium Co-administration of candesartan cilexetil with potassium sparing diuretics, potassium supplements, potassium-containing salt substitutes or other drugs that raise serum potassium levels may result in hyperkalemia. (bula de Candesartana, Interações medicamentosas)

  • PrazosinaalfabloqueadorModerada

    Syncopal episodes have usually occurred within 30 to 90 minutes of the initial dose of the drug; occasionally, they have been reported in association with rapid dosage increases or the introduction of another antihypertensive drug into the regimen of a patient taking high doses of prazosin hydrochloride capsules. (bula de Prazosina, Advertências)

  • Prilocaína + epinefrinaanestésico localModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • PseudoefedrinadescongestionanteModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • QuetiapinaantipsicóticoModerada

    Quetiapine should be used with particular caution in patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure, or conduction abnormalities), cerebrovascular disease, or conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications). (bula de Quetiapina, Advertências e precauções)

  • RepaglinidameglitinidaModerada

    Agents Increasing Serum Potassium Co-administration of candesartan cilexetil with potassium sparing diuretics, potassium supplements, potassium-containing salt substitutes or other drugs that raise serum potassium levels may result in hyperkalemia. (bula de Candesartana, Interações medicamentosas)

  • RiociguatevasodilatadorModerada

    Consider the potential for symptomatic hypotension or ischemia in patients with hypovolemia, severe left ventricular outflow obstruction, resting hypotension, autonomic dysfunction, or concomitant treatment with antihypertensives or strong CYP and P-gp/BCRP inhibitors [see Drug Interactions (7.2) and Clinical Pharmacology (12.3) ] . (bula de Riociguate, Advertências e precauções)

  • RisperidonaantipsicóticoModerada

    Clinically significant hypotension has been observed with concomitant use of oral RISPERDAL and antihypertensive medication. (bula de Risperidona, Advertências e precauções)

  • SalsalatoAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Sildenafilainibidor da PDE5Moderada

    Caution is advised when SILDENAFIL ORAL FILM is co-administered with alpha-blockers or antihypertensives. (bula de Sildenafila, Advertências e precauções)

  • SilodosinaalfabloqueadorModerada

    However, patients in the Phase 3 clinical studies taking concomitant antihypertensive medications with silodosin capsules did not experience a significant increase in the incidence of syncope, dizziness, or orthostasis. (bula de Silodosina, Advertências e precauções)

  • SorafenibeModerada

    Consider temporary or permanent discontinuation for severe or persistent hypertension despite antihypertensive therapy. (bula de Sorafenibe, Advertências e precauções)

  • SulindacoAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • Sumatriptana + naproxenotriptanoModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • SunitinibeModerada

    Initiate and/or adjust antihypertensive therapy as appropriate. (bula de Sunitinibe, Advertências e precauções)

  • TacrolimoimunossupressorModerada

    • Hypertension: May require antihypertensive therapy; monitor relevant drug interactions. (bula de Tacrolimo, Advertências e precauções)

  • Telmisartana + hidroclorotiazidabloqueador do receptor da angiotensina II (BRA)Moderada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • TerazosinaalfabloqueadorModerada

    Risk of Hypotension with Concomitant Use of Other Antihypertensive Agents and Phospodiesterase Type 5 Inhibitors (PDE5-I): Concomitant administration of TEZRULY with antihypertensives or phosphodiesterase-5 (PDE-5) inhibitors can result in additive blood pressure lowering effects and symptomatic hypotension (5.3). (bula de Terazosina, Advertências e precauções)

  • TestosteronaandrogênioModerada

    In patients with hypertension on antihypertensive therapy, TLANDO increased the mean systolic/diastolic BP by 4.8/1.6 mm Hg from baseline. [see Adverse Reactions ( 6.1 )] . (bula de Testosterona, Advertências e precauções)

  • TolmetinaAINEModerada

    NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect ( 7 ). (bula de Candesartana, Interações medicamentosas)

  • TolvaptanaModerada

    Monitor serum potassium during concomitant therapy with ( 7.2 ): Angiotensin receptor blockers Angiotensin converting enzyme inhibitors Potassium sparing diuretics 7.1 CYP3A Inhibitors and Inducers Strong CYP3A Inhibitors Tolvaptan's AUC was 5.4 times as large and C max was 3.5 times as large after co-administration of tolvaptan and 200 mg ketoconazole [see Warnings… (bula de Tolvaptana, Interações medicamentosas)

  • Torasemidadiurético de alçaModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • TrazodonaantidepressivoModerada

    Concomitant use with an antihypertensive may require a reduction in the dose of the antihypertensive drug. (bula de Trazodona, Advertências e precauções)

  • Trianterenodiurético poupador de potássioModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Triantereno + hidroclorotiazidadiurético poupador de potássioModerada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Valsartana + hidroclorotiazidabloqueador do receptor da angiotensina II (BRA)Moderada

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (bula de Candesartana, Advertências e precauções)

  • Vardenafilainibidor da PDE5Moderada

    Vardenafil hydrochloride tablets can potentiate the hypotensive effects of nitrates, alpha- blockers, and antihypertensives. (bula de Vardenafila, Interações medicamentosas)

  • VenlafaxinaIRSNModerada

    Metoprolol: Possibly reduced blood-pressure lowering effect despite increased metoprolol plasma levels. (bula de Venlafaxina, Interações medicamentosas)

  • Vibegronaagonista beta-adrenérgicoModerada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (bula de Candesartana, Advertências e precauções)

  • ZiprasidonaantipsicóticoModerada

    Ziprasidone should be used with particular caution in patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure or conduction abnormalities), cerebrovascular disease, or conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications). (bula de Ziprasidona, Advertências e precauções)

Menções leves (18)

  • ButorfanolopioideLeve

    In such cases, butorphanol should be discontinued and the hypertension treated with antihypertensive drugs. (bula de Butorfanol, Advertências)

  • ClorpromazinaantipsicóticoLeve

    Chlorpromazine may counteract the antihypertensive effect of guanethidine and related compounds. (bula de Clorpromazina, Advertências)

  • Desipraminaantidepressivo tricíclicoLeve

    This drug is capable of blocking the antihypertensive effect of guanethidine and similarly acting compounds. (bula de Desipramina, Advertências)

  • Desogestrel + etinilestradiolanticoncepcional oralLeve

    If other contraceptive methods are not suitable, hormonal contraceptive therapy may continue combined with antihypertensive therapy. (bula de Desogestrel + etinilestradiol, Advertências)

  • Dextroanfetaminaestimulante do SNCLeve

    Antihypertensives Amphetamines may antagonize the hypotensive effects of antihypertensives. (bula de Dextroanfetamina, Interações medicamentosas)

  • HidralazinavasodilatadorLeve

    When other potent parenteral antihypertensive drugs, such as diazoxide, are used in combination with hydralazine, patients should be continuously observed for several hours for any excessive fall in blood pressure. (bula de Hidralazina, Interações medicamentosas)

  • ACE Inhibitors FIRAZYR is a bradykinin B2 receptor antagonist and thereby has the potential to have a pharmacodynamic interaction with ACE inhibitors where FIRAZYR may attenuate the antihypertensive effect of ACE inhibitors. (bula de Icatibanto, Interações medicamentosas)

  • Isradipinobloqueador dos canais de cálcio di-hidropiridínicoLeve

    In a study in hypertensive patients, addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects, and isradipine had an additional antihypertensive effect. (bula de Isradipino, Interações medicamentosas)

  • Metildopaanti-hipertensivoLeve

    Drug Interactions When methyldopa is used with other antihypertensive drugs, potentiation of antihypertensive effect may occur. (bula de Metildopa, Interações medicamentosas)

  • MetoprololbetabloqueadorLeve

    Because of its relative beta 1 cardio-selectivity, however, Metoprolol Tartrate Tablets may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (bula de Metoprolol, Advertências e precauções)

  • MexiletinaantiarrítmicoLeve

    In a large compassionate use program mexiletine has been used concurrently with commonly employed antianginal, antihypertensive, and anticoagulant drugs without observed interactions. (bula de Mexiletina, Interações medicamentosas)

  • Nifedipinobloqueador dos canais de cálcio di-hidropiridínicoLeve

    Candesartan: No significant drug interaction has been reported in studies with candesartan cilexitil given together with nifedipine. (bula de Nifedipino, Interações medicamentosas)

  • Nisoldipinobloqueador dos canais de cálcio di-hidropiridínicoLeve

    The blood pressure effect of SULAR tended to be greater in patients on atenolol than in patients on no other antihypertensive therapy. (bula de Nisoldipino, Interações medicamentosas)

  • Nitroprusseto de sódiovasodilatadorLeve

    Hypertensive patients, and patients concomitantly receiving other antihypertensive medications, may be more sensitive to the effects of sodium nitroprusside than normal subjects. (bula de Nitroprusseto de sódio, Advertências)

  • Nortriptilinaantidepressivo tricíclicoLeve

    The antihypertensive action of guanethidine and similar agents may be blocked. (bula de Nortriptilina, Advertências)

  • ProclorperazinaantipsicóticoLeve

    Antihypertensive effects of guanethidine and related compounds may be counteracted when phenothiazines are used concomitantly. (bula de Proclorperazina, Precauções)

  • Protriptilinaantidepressivo tricíclicoLeve

    Protriptyline may block the antihypertensive effect of guanethidine or similarly acting compounds. (bula de Protriptilina, Advertências)

  • TrifluoperazinaantipsicóticoLeve

    Antihypertensive effects of guanethidine and related compounds may be counteracted when phenothiazines are used concurrently. (bula de Trifluoperazina, Precauções)

Verifique Candesartana com tudo o que você toma. Adicione sua lista completa; todos os pares são verificados de uma vez.

Abrir no verificador

Não é aconselhamento médico. A gravidade reflete a redação da bula, não as suas circunstâncias. Um alerta “grave” pode ser rotina sob supervisão, e um “leve” pode ser importante em doses altas. Pergunte a um farmacêutico.